Pruritus response and skin biomarkers of atopic dermatitis with crisaborole vs. vehicle in patients with mild-to-moderate atopic dermatitis

被引：0
|
作者：
Bissonnette, R. [1 ]
Guttman-Yassky, E. [2 ]
Werth, J. L. [3 ]
Zang, C. [3 ]
Cha, A. [4 ]
Vlahos, B. [3 ]
Myers, D. E. [3 ]
Nocka, K. H. [5 ]
Ports, W. C. [6 ]
机构：
[1] Innovaderm Res, Montreal, PQ, Canada
[2] Icahn Sch Med Mt Sinai, Lab Inflammatory Skin Dis, New York, NY 10029 USA
[3] Pfizer Inc, Collegeville, PA USA
[4] Pfizer Inc, New York, NY USA
[5] Pfizer Inc, Cambridge, MA USA
[6] Pfizer Inc, Groton, CT 06340 USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2020年 / 183卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P20
引用
收藏
页码：E104 / E104
页数：1
相关论文
共 50 条
  • [21] Crisaborole Ointment 2%: A Review in Mild to Moderate Atopic Dermatitis
    Hoy, Sheridan M.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2017, 18 (06) : 837 - 843
  • [22] Crisaborole ointment, 2%, in patients 3 months of age and older with mild-to-moderate atopic dermatitis (AD)
    Su, J. C.
    Spelman, L. J.
    Eichenfield, L. F.
    Gold, L. F. Stein
    Cha, A.
    Graham, D.
    Takiya, L.
    Werth, J. L.
    Zang, C.
    Vlahos, B.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 123 - 124
  • [23] Efficacy And Safety Of Crisaborole In Patients Aged 3 Months To 17 Years With Mild-To-Moderate Atopic Dermatitis
    Su, John C.
    Spelman, Lynda J.
    Eichenfield, Lawrence F.
    Stein, Linda F.
    Cha, Amy
    Graham, Daniela
    Takiya, Liza
    Werth, John L.
    Zang, Chuanbo
    Vlahos, Bonnie
    PEDIATRICS, 2021, 147 (03)
  • [24] Improvements in Sleep Outcomes for Crisaborole-treated Pediatric Patients with Mild-to-moderate Atopic Dermatitis and Their Families
    Fowler, Joseph
    Sugarman, Jeffrey
    Sher, Lawrence
    Zang, Chuanbo
    Werth, John L.
    Myers, Daniela E.
    Graham, Daniela
    Takiya, Liza
    PEDIATRICS, 2022, 149 (01)
  • [25] Crisaborole demonstrates improvement in quality of life in patients with mild to moderate atopic dermatitis
    Simpson, E.
    Paller, A.
    Boguniewicz, M.
    Eichenfield, L.
    Feldman, S.
    Silverberg, J.
    Chamlin, S.
    Zane, L.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 28 - 29
  • [26] Treatment preferences among patients with mild-to-moderate atopic dermatitis
    Myers, Kelley
    Silverberg, Jonathan I.
    Parasuraman, Shreekant
    Pierce, Anna
    Eichenfield, Lawrence F.
    Poulos, Christine
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [27] Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis
    Howard Thom
    Vincent Cheng
    Edna Keeney
    Maureen P. Neary
    Anthony Eccleston
    Chuanbo Zang
    Joseph C. Cappelleri
    Amy Cha
    Jacob P. Thyssen
    Dermatology and Therapy, 2022, 12 : 185 - 194
  • [28] Evaluation of a Pseudoceramide Moisturizer in Patients with Mild-to-Moderate Atopic Dermatitis
    Seghers A.C.
    Cai S.C.
    Ho M.S.L.
    Giam Y.C.
    Tan L.
    Grönhagen C.M.
    Tang M.B.Y.
    Dermatology and Therapy, 2014, 4 (1) : 83 - 92
  • [29] Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial
    Bissonnette, Robert
    Pavel, Ana B.
    Diaz, Aisleen
    Werth, John L.
    Zang, Chuanbo
    Vranic, Ivana
    Purohit, Vivek S.
    Zielinski, Michael A.
    Vlahos, Bonnie
    Estrada, Yeriel D.
    Proulx, Etienne Saint-Cyr
    Ports, William C.
    Guttman-Yassky, Emma
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (05) : 1274 - 1289
  • [30] CRISABOROLE DEMONSTRATES IMPROVEMENT IN QUALITY OF LIFE IN PATIENTS WITH MILD TO MODERATE ATOPIC DERMATITIS
    Simpson, E.
    Paller, A.
    Boguniewicz, M.
    Eichenfield, L.
    Feldman, S.
    Silverberg, J.
    Chamlin, S.
    Zane, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2016, 117 (05) : S20 - S21
12345